A Retrospective Study on the Effect of Male Progressive Sperm Count After Semen Pretreatment on ICSI Fertilization Outcome
NCT ID: NCT03594201
Last Updated: 2019-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12215 participants
OBSERVATIONAL
2016-01-01
2018-01-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ICSI Versus Conventional IVF in Couples With Non-severe Male Infertility
NCT03298633
Prospective, Randomized Trial Comparing ICSI to Insemination for Non-Male Factor Patients Undergoing PGT-A
NCT05548101
ICSI Outcome of Ejaculated Versus Extracted Testicular Spermatozoa
NCT03033563
Is the Lack of Prior Exposure to Sperm Antigens Associated With Worse Neonatal and Maternal Outcomes?
NCT04852237
Effectiveness of Intracytoplasmic Sperm Injection and Laser Assisted Hatching on in Vitro Fertilization Outcomes of Patients With Different Causes of Infertility
NCT02026661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group1
A+B grade sperm count after treatment=0
semen pretreatment
semen pretreatment
group2
0\<A+B grade sperm count after treatment≤10\^6
semen pretreatment
semen pretreatment
group3
10\^6\<A+B grade sperm count after treatment\<2\*10\^6
semen pretreatment
semen pretreatment
group4
A+B grade sperm count after treatment≥2\*10\^6
semen pretreatment
semen pretreatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
semen pretreatment
semen pretreatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* none retrieval oocyte
* none oocyte for ICSI
* Recurrent abortion
* female age≥37 years
* Assisted hatching
* abnormal oocyte zona pellucida
* In Vitro Maturation
* AZF microdeletion
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reproductive & Genetic Hospital of CITIC-Xiangya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liang Hu, MD,PHD
Role: PRINCIPAL_INVESTIGATOR
Reproductive & Genetic Hospital of CITIC-Xiangya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reproductive & Genetic Hospital of CITIC-XIANGYA
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KYXM-201803
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.